Terms: = Skin cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
888 results:
1. Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Versluis JM; Blankenstein SA; Dimitriadis P; Wilmott JS; Elens R; Blokx WAM; van Houdt W; Menzies AM; Schrage YM; Wouters MWJM; Sanders J; Broeks A; Scolyer RA; Suijkerbuijk KPM; Long GV; Akkooi ACJV; Blank CU
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38677880
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract] [Full Text] [Related]
3. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
[TBL] [Abstract] [Full Text] [Related]
4. Primary cutaneous anaplastic large-cell lymphoma resembling infratemporal space infection: a case report.
Yan X; Ren W; Li S; Zhu Z; Gao L; Zhi K
BMC Oral Health; 2024 Apr; 24(1):470. PubMed ID: 38637781
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell sequencing analysis and multiple machine-learning models revealed the cellular crosstalk of dendritic cells and identified FABP5 and KLRB1 as novel biomarkers for psoriasis.
Ma Z; An P; Hao S; Huang Z; Yin A; Li Y; Tian J
Front Immunol; 2024; 15():1374763. PubMed ID: 38596682
[TBL] [Abstract] [Full Text] [Related]
6. BRAF V600E Mutation in Malignant Melanoma-A Romanian Research Experience.
Avădănei ER; Căruntu ID; Nucă I; Balan R; Lozneanu L; Giusca SE; Amalinei C
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541077
[No Abstract] [Full Text] [Related]
7. Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression.
Nakamura M; Yoshimitsu M; Magara T; Kano S; Kato H; Morita A
Exp Dermatol; 2024 Mar; 33(3):e15062. PubMed ID: 38532566
[TBL] [Abstract] [Full Text] [Related]
8. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
Su DG; Schoenfeld DA; Ibrahim W; Cabrejo R; Djureinovic D; Baumann R; Rimm DL; Khan SA; Halaban R; Kluger HM; Olino K; Galan A; Clune J
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519058
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides.
Porkert S; Griss J; Hudelist-Venz M; Steiner I; Valencak J; Weninger W; Brunner PM; Jonak C
J Dtsch Dermatol Ges; 2024 Apr; 22(4):532-550. PubMed ID: 38444271
[TBL] [Abstract] [Full Text] [Related]
10. Loss of miR-101-3p in melanoma stabilizes genomic integrity, leading to cell death prevention.
Lämmerhirt L; Kappelmann-Fenzl M; Fischer S; Meier P; Staebler S; Kuphal S; Bosserhoff AK
Cell Mol Biol Lett; 2024 Mar; 29(1):29. PubMed ID: 38431560
[TBL] [Abstract] [Full Text] [Related]
11. The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Feichtenschlager V; Chen L; Zheng YJ; Ho W; Sanlorenzo M; Vujic I; Fewings E; Lee A; Chen C; Callanan C; Lin K; Qu T; Hohlova D; Vujic M; Hwang Y; Lai K; Chen S; Nguyen T; Muñoz DP; Kohwi Y; Posch C; Daud A; Rappersberger K; Kohwi-Shigematsu T; Coppé JP; Ortiz-Urda S
Mol Cancer; 2024 Feb; 23(1):40. PubMed ID: 38383439
[TBL] [Abstract] [Full Text] [Related]
12. Duodenal malignant melanoma: Primary and metastatic case series and literature review.
Zhou B; Li X; Liu J; Peng L; Liu X
Medicine (Baltimore); 2024 Feb; 103(6):e37138. PubMed ID: 38335433
[TBL] [Abstract] [Full Text] [Related]
13. Targeting cd20-expressing malignant melanoma cells augments BRAF inhibitor killing.
Mukhtar AB; Morgan HJ; Gibbs A; Davies GE; Lovatt C; Patel GK
Br J Dermatol; 2024 Apr; 190(5):729-739. PubMed ID: 38288865
[TBL] [Abstract] [Full Text] [Related]
14. Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review.
Serbest Ceylanoglu K; Guneri Beser B; Singalavanija T; Juntipwong S; Worden FP; Demirci H
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):18-29. PubMed ID: 38241616
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical pathological and genetic mutation characteristics of conjunctival lymphoepithelial carcinoma].
Wang YC; Li J; Guo YT; Li J; Lin JY
Zhonghua Yan Ke Za Zhi; 2024 Jan; 60(1):64-71. PubMed ID: 38199770
[No Abstract] [Full Text] [Related]
16. cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register.
Molina-Collada J; Alonso F; Otero L; Bohórquez C; Díaz Torné C; Pérez García C; Blanco Madrigal JM; Vela P; Álvaro-Gracia JM; Castrejón I;
Semin Arthritis Rheum; 2024 Feb; 64():152341. PubMed ID: 38128174
[TBL] [Abstract] [Full Text] [Related]
17. Primary cutaneous marginal zone lymphoproliferative disorder following COVID-19 vaccination.
Stephan C; Barone P; Kim J; Ma L
J Cutan Pathol; 2024 Mar; 51(3):193-197. PubMed ID: 38018231
[TBL] [Abstract] [Full Text] [Related]
18. Folliculotropic Mycosis Fungoides In A Child: A Rare Case.
Zahoor F; Junaid S; Afzal G
J Pak Med Assoc; 2023 Nov; 73(11):2260-2262. PubMed ID: 38013542
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
20. Combining CSPG4-CAR and cd20-CCR for treatment of metastatic melanoma.
Teppert K; Winter N; Herbel V; Brandes C; Lennartz S; Engert F; Kaiser A; Schaser T; Lock D
Front Immunol; 2023; 14():1178060. PubMed ID: 37901209
[TBL] [Abstract] [Full Text] [Related]
[Next]
